Dubai, United Arab Emirates, 2nd Dec 2024 – World blockchain firm GenomeFi garnered important consideration at KoINDEX 2024, held from November 21 to 23 on the YashoBhoomi Exhibition Middle in New Delhi, India, by showcasing its AI-powered Web3 genomic Decentralized Id (DID) platform.
KoINDEX 2024, a world industrial exhibition, commemorated the fiftieth anniversary of Korea-India diplomatic relations, aiming to strengthen financial cooperation between the 2 nations and help the worldwide enlargement of South Korean SMEs. The occasion concluded efficiently, that includes over 280 corporations, 600 cubicles, and greater than 14,000 guests.
On the exhibition, GenomeFi demonstrated its progressive platform for securely defending and using healthcare information, strengthening its presence within the international market, and exploring collaborative alternatives throughout the Indian market.

GenomeFi unveiled its genome-based DID platform, which integrates AI and blockchain to current new potentialities for healthcare information utilization. Its expertise, designed to reinforce information safety and possession safety whereas fostering an incentive-based ecosystem, attracted important curiosity from native healthcare professionals.
A medical skilled remarked, “GenomeFi’s technology addresses critical data security challenges and opens up possibilities for personalized medical services,” highlighting its immense worth.
Through the exhibition, GenomeFi’s sales space attracted over 1,500 guests. Attendees skilled its AI-driven genomic evaluation companies firsthand and discovered how personalised medical options have the potential to rework the healthcare trade.
Along with its sales space actions, GenomeFi participated within the Know-how and Healthcare Innovation Seminar at KoINDEX 2024, presenting on the transformative influence of AI and blockchain integration on the healthcare trade. The corporate additionally engaged in collaboration discussions with 15 native medical establishments and biotech corporations, solidifying pilot tasks with 5 of them.
By way of KoINDEX 2024, GenomeFi demonstrated its technological management within the international market and validated its potential for enlargement into India and different Asian markets. Interactions with main healthcare and tech corporations paved the way in which for growing localized healthcare options tailor-made to the area’s wants.
GenomeFi plans to launch its first collaborative undertaking within the Indian market by the primary half of 2025. This undertaking goals to research genomic information from over 30,000 people and ship personalised medical companies, setting new benchmarks for healthcare information utilization.
KoINDEX 2024 showcased how the fusion of AI and blockchain can revolutionize the way forward for the healthcare trade. GenomeFi has confirmed its readiness to pioneer a brand new paradigm in healthcare by defending information possession and enabling personalised medical companies. The corporate is dedicated to increasing progressive healthcare options in international markets by way of ongoing collaborations, solidifying its place as a pacesetter in healthcare information innovation.
Media Contact
Group: Genomefi
Contact Particular person: Soonzero
Web site: https://genomefi.io/
Electronic mail: Ship Electronic mail
Metropolis: Dubai
Nation: United Arab Emirates
Launch Id: 02122420742
The publish GenomeFi Beneficial properties Recognition for Revolutionary Healthcare Know-how at KoINDEX 2024 appeared on King Newswire. It’s supplied by a third-party content material supplier. King Newswire makes no warranties or representations in reference to it.